(19)
(11) EP 4 214 511 A1

(12)

(43) Date of publication:
26.07.2023 Bulletin 2023/30

(21) Application number: 21782657.7

(22) Date of filing: 17.09.2021
(51) International Patent Classification (IPC): 
G01N 33/569(2006.01)
C12Q 1/6888(2018.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/56983; G01N 2333/165; G01N 2333/948
(86) International application number:
PCT/EP2021/075660
(87) International publication number:
WO 2022/058526 (24.03.2022 Gazette 2022/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.09.2020 GB 202014755

(71) Applicant: Randox Laboratories Ltd.
Crumlin Antrim BT29 4QY (GB)

(72) Inventors:
  • FITZGERALD, Peter
    Antrim BT29 4QY (GB)
  • MCCONNELL, Ivan
    Antrim BT29 4QY (GB)
  • LAMONT, John
    Antrim BT29 4QY (GB)
  • CURRY, Jim
    Antrim BT29 4QY (GB)
  • LOWRY, Philip
    Antrim BT29 4QY (GB)

   


(54) METHODS TO DETERMINE CORONAVIRUS INFECTIVITY STATUS